417 related articles for article (PubMed ID: 23001645)
1. Enantiomeric specificity of biologically significant Cu(II) and Zn(II) chromone complexes towards DNA.
Arjmand F; Jamsheera A; Afzal M; Tabassum S
Chirality; 2012 Dec; 24(12):977-86. PubMed ID: 23001645
[TBL] [Abstract][Full Text] [Related]
2. New heterobimetallic Cu(II)-Sn2(IV) complex as potential topoisomerase I inhibitor: in vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines.
Tabassum S; Afzal M; Arjmand F
J Photochem Photobiol B; 2012 Oct; 115():63-72. PubMed ID: 22884481
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of new chiral heterocyclic Schiff base modulated Cu(II)/Zn(II) complexes: their comparative binding studies with CT-DNA, mononucleotides and cleavage activity.
Arjmand F; Sayeed F; Muddassir M
J Photochem Photobiol B; 2011 May; 103(2):166-79. PubMed ID: 21459607
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and in vitro DNA binding and cleavage studies of Cu(II)/Zn(II) dipeptide complexes.
Arjmand F; Jamsheera A; Mohapatra DK
J Photochem Photobiol B; 2013 Apr; 121():75-85. PubMed ID: 23518161
[TBL] [Abstract][Full Text] [Related]
5. Enantiomeric fluoro-substituted benzothiazole Schiff base-valine Cu(II)/Zn(II) complexes as chemotherapeutic agents: DNA binding profile, cleavage activity, MTT assay and cell imaging studies.
Alizadeh R; Yousuf I; Afzal M; Srivastav S; Srikrishna S; Arjmand F
J Photochem Photobiol B; 2015 Feb; 143():61-73. PubMed ID: 25600265
[TBL] [Abstract][Full Text] [Related]
6. Chiral preference of L-tryptophan derived metal-based antitumor agent of late 3d-metal ions (Co(II), Cu(II) and Zn(II)) in comparison to D- and DL-tryptophan analogues: their in vitro reactivity towards CT DNA, 5'-GMP and 5'-TMP.
Arjmand F; Muddassir M; Khan RH
Eur J Med Chem; 2010 Sep; 45(9):3549-57. PubMed ID: 20537435
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and enantiopreferential DNA-binding profile of late 3d transition metal R- and S-enantiomeric complexes derived from N,N-bis-(1-benzyl-2-ethoxyethane): Validation of R-enantiomer of copper(II) complex as a human topoisomerase II inhibitor.
Arjmand F; Sharma GC; Muddassir M; Tabassum S
Chirality; 2011 Aug; 23(7):557-67. PubMed ID: 21695735
[TBL] [Abstract][Full Text] [Related]
8. DNA binding studies of novel Copper(II) complexes containing L-tryptophan as chiral auxiliary: in vitro antitumor activity of Cu-Sn2 complex in human neuroblastoma cells.
Chauhan M; Banerjee K; Arjmand F
Inorg Chem; 2007 Apr; 46(8):3072-82. PubMed ID: 17378549
[TBL] [Abstract][Full Text] [Related]
9. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of enantiomeric (R)- and (S)-copper(II) and diorganotin(IV)-based antitumor agents: their in vitro DNA binding profile, cleavage efficiency and cytotoxicity studies.
Arjmand F; Muddassir M; Yousuf I
J Photochem Photobiol B; 2014 Jul; 136():62-71. PubMed ID: 24857791
[TBL] [Abstract][Full Text] [Related]
11. New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity.
Tabassum S; Zaki M; Afzal M; Arjmand F
Dalton Trans; 2013 Jul; 42(27):10029-41. PubMed ID: 23715526
[TBL] [Abstract][Full Text] [Related]
12. Enantiomeric in vitro DNA binding, pBR322 DNA cleavage and molecular docking studies of chiral L- and D-ternary copper(II) complexes of histidine and picolinic acid.
Parveen S; Arjmand F; Ahmad I
J Photochem Photobiol B; 2014 Jan; 130():170-8. PubMed ID: 24333765
[TBL] [Abstract][Full Text] [Related]
13. A mechanistic approach for the DNA binding of chiral enantiomeric L- and D-tryptophan-derived metal complexes of 1,2-DACH: cleavage and antitumor activity.
Arjmand F; Muddassir M
Chirality; 2011 Mar; 23(3):250-9. PubMed ID: 20928895
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of dinuclear macrocyclic cobalt(II), copper(II) and zinc(II) complexes derived from 2,2,2('),2(')-S,S[bis(bis-N,N-2-thiobenzimidazolyloxalato-1,2-ethane)]: DNA binding and cleavage studies.
Arjmand F; Aziz M
Eur J Med Chem; 2009 Feb; 44(2):834-44. PubMed ID: 18579258
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid-DACH conjugate: comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies.
Arjmand F; Yousuf I; Hadda Tb; Toupet L
Eur J Med Chem; 2014 Jun; 81():76-88. PubMed ID: 24826817
[TBL] [Abstract][Full Text] [Related]
16. Interaction of rac-[Cu(diimine)3]2+ and rac-[Zn(diimine)3]2+ complexes with CT DNA: effect of fluxional Cu(II) geometry on DNA binding, ligand-promoted exciton coupling and prominent DNA cleavage.
Ramakrishnan S; Palaniandavar M
Dalton Trans; 2008 Aug; (29):3866-78. PubMed ID: 18629409
[TBL] [Abstract][Full Text] [Related]
17. Study on synthesis, structure, and DNA-binding of Ni, Zn complexes with 2-phenylquinoline-4-carboylhydrazide.
Xi PX; Xu ZH; Chen FJ; Zeng ZZ; Zhang XW
J Inorg Biochem; 2009 Feb; 103(2):210-8. PubMed ID: 19026448
[TBL] [Abstract][Full Text] [Related]
18. Cu(II), Ni(II) complexes derived from chiral Schiff-base ligands: Synthesis, characterization, cytotoxicity, protein and DNA-binding properties.
Li Z; Yan H; Chang G; Hong M; Dou J; Niu M
J Photochem Photobiol B; 2016 Oct; 163():403-12. PubMed ID: 27619741
[TBL] [Abstract][Full Text] [Related]
19. Zinc(II) complexes of Pro-Gly and Pro-Leu dipeptides: synthesis, characterization, in vitro DNA binding and cleavage studies.
Parveen S; Arjmand F; Mohapatra DK
J Photochem Photobiol B; 2013 Sep; 126():78-86. PubMed ID: 23911763
[TBL] [Abstract][Full Text] [Related]
20. Induction of cell death by ternary copper(II) complexes of L-tyrosine and diimines: role of coligands on DNA binding and cleavage and anticancer activity.
Ramakrishnan S; Rajendiran V; Palaniandavar M; Periasamy VS; Srinag BS; Krishnamurthy H; Akbarsha MA
Inorg Chem; 2009 Feb; 48(4):1309-22. PubMed ID: 19140687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
